Sleep dysregulation in sympathetic-mediated diseases: implications for disease progression
dc.contributor.author | Jose Olivares, Maria | |
dc.contributor.author | Toledo, Camilo | |
dc.contributor.author | Ortolani, Domiziana | |
dc.contributor.author | Ortiz, Fernando C. | |
dc.contributor.author | Diaz, Hugo S. | |
dc.contributor.author | Iturriaga, Rodrigo | |
dc.contributor.author | Del Rio, Rodrigo | |
dc.date.accessioned | 2025-01-20T21:03:37Z | |
dc.date.available | 2025-01-20T21:03:37Z | |
dc.date.issued | 2022 | |
dc.description.abstract | The autonomic nervous system (ANS) plays an important role in the coordination of several physiological functions including sleep/wake process. Significant changes in ANS activity occur during wake-to-sleep transition maintaining the adequate cardiorespiratory regulation and brain activity. Since sleep is a complex homeostatic function, partly regulated by the ANS, it is not surprising that sleep disruption trigger and/or evidence symptoms of ANS impairment. Indeed, several studies suggest a bidirectional relationship between impaired ANS function (i.e. enhanced sympathetic drive), and the emergence/development of sleep disorders. Furthermore, several epidemiological studies described a strong association between sympathetic-mediated diseases and the development and maintenance of sleep disorders resulting in a vicious cycle with adverse outcomes and increased mortality risk. However, which and how the sleep/wake control and ANS circuitry becomes affected during the progression of ANS-related diseases remains poorly understood. Thus, understanding the physiological mechanisms underpinning sleep/wake-dependent sympathetic modulation could provide insights into diseases involving autonomic dysfunction. The purpose of this review is to explore potential neural mechanisms involved in both the onset/maintenance of sympathetic-mediated diseases (Rett syndrome, congenital central hypoventilation syndrome, obstructive sleep apnoea, type 2 diabetes, obesity, heart failure, hypertension, and neurodegenerative diseases) and their plausible contribution to the generation of sleep disorders in order to review evidence that may serve to establish a causal link between sleep disorders and heightened sympathetic activity. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1093/sleep/zsac166 | |
dc.identifier.eissn | 1550-9109 | |
dc.identifier.issn | 0161-8105 | |
dc.identifier.uri | https://doi.org/10.1093/sleep/zsac166 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/93160 | |
dc.identifier.wosid | WOS:000838254100001 | |
dc.issue.numero | 11 | |
dc.language.iso | en | |
dc.revista | Sleep | |
dc.rights | acceso restringido | |
dc.subject | sleep regulation | |
dc.subject | autonomic nervous system | |
dc.subject | arousal | |
dc.subject | sympathetic hyperactivity | |
dc.subject | sympathetic-mediated diseases | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Sleep dysregulation in sympathetic-mediated diseases: implications for disease progression | |
dc.type | artículo | |
dc.volumen | 45 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |